Mohammad Afshar (CEO) presents Ariana’s Onco KEM® tool at the prestigious French American Innovation Day (FAID) 2016, gathering world renowned experts in precision medicine.
FAID 2016 – PRECISION MEDICINE & NEW TECHNOLOGIES: TRANSFORMING CLINICAL RESEARCH
February 9-10, 2016
MIT Media Lab, 75 Amherst St, Cambridge, MA
“Software as a therapeutic: The challenge of transforming big Data into a cancer treatment selection tool (Onco KEM®) and measuring its therapeutic impact in an international clinical trial”, Dr Mohammad Afshar, Ariana Pharma, France